Back to results
US 2024/0197642 A1Published application
Novel drug delivery composition and process for blood-brain barrier crossing
AssigneeCytodigm, Inc.
InventorsBin Wu, Nicholas J. Boylan, Zimeng Wang, Jienu Xu
Life of this patent
Estimating the term…
Abstract
This invention provides polymeric nanoparticles presenting non-conjugated BBB-crossing ligands on their surfaces, compositions and methods of use thereof, as well as non-conjugation methods to produce nanoparticles having BBB-crossing agents on their surfaces.
Claims14
A method of delivering an active agent to a central nervous system in a mammal comprising administering particles encapsulating the active agent comprising a biodegradable polymer and a surfactant intertwined on the surface thereof.
Dependencies are inferred from the claim text.